Konyang University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Nonsan Korea, Republic of (1991)

Organization Overview

First Clinical Trial
2008
NCT01378104
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Konyang University Hosipital | Konyang University Hospital | Konyang University Hospital of Korea | Konyang University School of Medicine & Konyang University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyspepsia (Phase 4)

Esophagitis (Phase 4)

Esophagitis, Peptic (Phase 4)

Essential Hypertension (Phase 3)

Gastritis (Phase 4)

Gastroesophageal Reflux (Phase 4)

Hepatitis (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypertension (Phase 3)

Kidney Failure, Chronic (Phase 4)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Pancreatic Neoplasms (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Renal Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 20